Cure of cutaneous melanoma.

Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol (2004) 5.49

Cutaneous melanoma in relation to intermittent and constant sun exposure--the Western Canada Melanoma Study. Int J Cancer (1985) 2.37

Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control (2001) 2.21

Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control (2006) 1.80

Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol (2005) 1.68

Caution with sentinel node biopsy in cutaneous melanoma. Br J Surg (2006) 1.45

Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health (2005) 1.10

The rationale of the ABCDs of early melanoma. J Am Acad Dermatol (1993) 1.01

Seven-point checklist for melanoma. Clin Exp Dermatol (1991) 0.96

Soft-tissue sarcomas in adults. N Engl J Med (2005) 5.97

Retroperitoneal tumours: review of management. Ann R Coll Surg Engl (2011) 1.42

Does the two-week rule pathway improve the diagnosis of soft tissue sarcoma? A retrospective review of referral patterns and outcomes over five years in a regional sarcoma centre. Ann R Coll Surg Engl (2010) 1.28

Aggressive fibromatosis: MRI features with pathologic correlation. AJR Am J Roentgenol (2006) 1.23

Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol (2004) 1.19

A gene expression signature associated with metastatic outcome in human leiomyosarcomas. Cancer Res (2004) 1.18

Transmission of donor melanoma by organ transplantation. Lancet Oncol (2010) 1.15

Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol (2013) 1.12

Adult rhabdomyosarcoma: cross-sectional imaging findings including histopathologic correlation. AJR Am J Roentgenol (2007) 1.12

Malignancies confined to disused arteriovenous fistulae in renal transplant patients: an important differential diagnosis. Am J Nephrol (2011) 0.97

Amputation for soft-tissue sarcoma. Lancet Oncol (2003) 0.95

Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin. ANZ J Surg (2008) 0.95

The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigment Cell Melanoma Res (2014) 0.95

Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma. Ann Surg Oncol (2007) 0.95

The radiological manifestations of intramuscular haemangiomas in adults: magnetic resonance imaging, computed tomography and ultrasound appearances. Skeletal Radiol (2007) 0.93

What does the medical profession mean by "standard of care?". J Clin Oncol (2009) 0.91

Gastric necrosis in a patient with bulimia. Eur J Surg (2002) 0.91

Sentinel lymph node biopsy in malignant melanoma. BMJ (2008) 0.91

Intra-abdominal metastases from soft tissue sarcoma. J Surg Oncol (2004) 0.90

A quality-of-life study in high-risk (thickness > = or 2 mm) cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins. J Investig Dermatol Symp Proc (2004) 0.89

Sentinel lymph node biopsy: not yet standard of care for melanoma. BMJ (2004) 0.89

Prognostic false-positivity and cost-effectiveness in sentinel node biopsy in melanoma. Ann Surg Oncol (2009) 0.87

Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma. J Am Acad Dermatol (2009) 0.87

Sentinel-node biopsy in melanoma. N Engl J Med (2014) 0.87

Management of benign retroperitoneal schwannomas: a single-center experience. Am J Surg (2011) 0.86

Portsite recurrence after laparoscopy for staging of retroperitoneal sarcoma. Surg Laparosc Endosc Percutan Tech (2003) 0.84

Sentinel lymph node biopsy as the standard of care for cutaneous melanoma. Clin Adv Hematol Oncol (2007) 0.82

Angiosarcoma developing in a non-functioning arteriovenous fistula post-renal transplant. J Surg Oncol (2010) 0.79

Where is the evidence base for benefits of sentinel node biopsy in melanoma? BMJ (2013) 0.79

Sentinel-node biopsy in melanoma. N Engl J Med (2007) 0.78

Primary malignant tumors of the iliopsoas compartment. J Surg Oncol (2004) 0.78

Synchronous mantle cell lymphoma, chronic lymphocytic leukaemia and melanoma in a single lymph node. Acta Haematol (2010) 0.78

Some of the 2009 American Joint Committee on Cancer melanoma staging and classification is not evidence based. J Clin Oncol (2010) 0.75

Are there guidance issues relating to sentinel node biopsy for melanoma in the UK? Br J Plast Surg (2004) 0.75

False-positivity in the sentinel lymph nodes in melanoma and breast cancer. Cancer (2010) 0.75

Sydney Melanoma Unit patients in breach of multicentre selective lymphadenectomy trial protocol? ANZ J Surg (2006) 0.75

Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma (Br J Surg 2007; 94: 1293-1299). Br J Surg (2008) 0.75

Time for comprehensive reporting of MSLT-I. Lancet Oncol (2006) 0.75

Lymphoedema in the observation and biopsy arms of MSLT-1. Ann Surg Oncol (2011) 0.75

Dermatologists should exert a greater influence over sentinel lymph node biopsy for melanoma in the U.K. Br J Dermatol (2005) 0.75

Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med (2011) 0.75

Dr. Herbert Lumley Snow, MD, MRCS (1847-1930): the original champion of elective lymph node dissection in melanoma. Ann Surg Oncol (2004) 0.75

Mastering ear cartilage sculpture: the vegetarian option. Plast Reconstr Surg (2005) 0.75

Expectoration of endobronchial sarcoma metastasis. ANZ J Surg (2004) 0.75